ArticleScientific reports2025
Comparative analysis of sLASER and PRESS techniques for magnetic resonance spectroscopy of the normal human brain.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Point-resolved spectroscopy is commonly used for magnetic resonance spectroscopy (MRS) due to widespread clinical availability, yet its accuracy can be compromised by chemical shift displacement error (CSDE) and sensitivity to magnetic field inhomogeneities, particularly near cerebrospinal fluid (CSF)-rich areas. Semi-localization by adiabatic selective refocusing (sLASER) mitigates these issues through superior voxel localization, reducing susceptibility to CSDE and B1 inhomogeneity. However, direct clinical comparisons between PRESS and sLASER, especially under matched acquisition conditions, remain scarce. This study aimed to directly compare PRESS and sLASER sequences regarding metabolite quantification accuracy and spectral quality in brain regions adjacent to CSF, under identical water suppression scheme. Thirty healthy adult volunteers (17 men; mean age, 40 ± 9.6 years) were recruited between January and July 2023. MRS data were acquired with PRESS and sLASER sequences at the left medial thalamus (near the third ventricle), using identical voxel placement and water suppression scheme of VAPOR. Metabolite concentrations were quantified using LCModel, and spectral quality metrics including residual water peak height, spectral signal-to-noise ratio (SNR), and spectral linewidth were also analyzed. As a result, compared to PRESS, sLASER yielded significantly higher concentration of NAA + NAAG, whereas Gly + mI were significantly lower (all, FDR adjusted q < 0.05). Spectral SNR was significantly higher (+ 24%, P < 0.001), but residual water peak height and spectral linewidth did not differ significantly (P > 0.05). Variability analysis indicated significantly higher coefficient of variation for Glu + Gln with sLASER (P < 0.05). In conclusion, in CSF-adjacent region, sLASER significantly increased spectral SNR but also exhibited greater variability in concentration for specific J-coupled metabolite. Therefore, although sLASER improved certain spectral quality aspects, caution is warranted due to higher variability in metabolite quantifications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.